Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When a company issues additional shares...
There are many scenarios in which a firm could require an equity capital infusion; funds may simply be needed to cover expenses. In a scenario where a firm does not have the capital to service current liabilities and the firm is hindered from issuing new debt due to covenants of existing debt, an equity offering of new shares may be necessary.
Growth opportunities are another indicator of a potential share dilution. Secondary offerings are commonly used to obtain investment capital that may be needed to fund large projects and new ventures.
reference: insert-text-here[color=red][/color]
Some interesting signals popping up according to www.barchart.com
20 Day Moving Average vs Price= Buy
50 Day Parabolic Time/Price= Buy
40 Day Commodity Channel Index= Hold
60 Day Commodity Channel Index= Hold
20 Day Bollinger Bands= Hold
10 - 8 Day Moving Average Hilo Channel= Hold
IMO a possible breakout is looming. BTW for all of you that think this company is a scam it is NOT. The companies CASH is somewhat a concern for me too. I have had many email correspondents from the CEO in the past few weeks. He is working HARD to turn this ship around. You heard it here first!BTW folks I am not a pumper or dumper...I am an INVESTOR and this is just MY OPINIONS. Thank you.
GODSPEED, happy investing,and I appreciate all of your opinions
I agree. I could even see ONCS in the one dollar range in a week or two. ONCOSEC will make all of us some good money here in the near future and most importantly closer to a cure for these horrible medical conditions. What we have been experiencing is a normal and healthy pull back. No big deal...the pullback kind of reminds me of a little company last year that made me a lot of money and looks poised to do it again. I.E. Nano Labs Corp. (CTLE), much like the CEO of ONCOSEC Nano Labs CEO is very accessible. The sock has been beaten down recently...perfect time to buy. IMO
ONCS=LONG
CTLE=LONG
Just food for thought. GODSPEED
"update to shareholders regarding the Company direction"
Nano Labs Corp. (OTCQB:CTLE) is pleased to provide the following update to shareholders regarding the Company direction and vision for 2014.
Dear Shareholders,
Over the past 18 months the company has worked with Dr. Castano, our team of researchers, designers, and engineers on creating a portfolio of advanced nano technology that will provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare.
Since entering into an Asset Purchase Agreement with Dr. Victor Castano on October 10, 2012 the company has followed Dr. Castano's lead and filed Intellectual Patents after reviewing several of Dr. Castano's publications. The first product identified by the company to take to market was the Nano Coatings technology.
The Nano Coatings were produced in the laboratory environment and tested under ASTM and Underwriters Laboratory protocol by several testing facilities. The company has also approached several manufactures to produce the product under license over the past 18 months. However, the company experienced consistent problems with the manufacturing of the Nano Coatings as it applies to developing several other coatings applications for uses in the Nano Nail Polish and LED system.
The Board of Directors has determined that the outstanding manufacturing issues to be resolved with the coatings technology were extensive and problematic, and it is in the best interest of the company to pursue our other opportunities such as Polec Industries and industry sectors not related to the Nano Coatings at this time.
The Board of Directors agreed that the consummation of the Asset Purchase Agreement is not in the best interests of the Company or its shareholders in light of certain difficulties pertaining to the intellectual property, testing, and the production of the Nano Coating Technology and other products provided by Dr. Castano using his Nano Coating Technology.
The Company has determined and agreed with Dr. Castano that the Asset Purchase Agreement should be rescinded (the "Rescission") and that all right, title and interest in and to the Nano Coating Technology and products publications be returned to Dr. Castano. Dr. Castano has accepted to rescind the Asset Purchase Agreement and return 101 million common shares of Nano labs Corp to the Company for cancelation.
The Rescission Agreement was signed on March 4th, 2014 with Dr. Castano, and the Company received the resignation of Dr. Victor Castano as Chairman and Chief Technology Officer on the same day.
We continue to follow our core strategy of developing a diversified investment of nanotechnologies for our shareholders in Nano Labs. The Company will continue negotiations with Polec Industries and other potential opportunities currently under review. The Company is also in the process of interviewing several potential high-level candidates to replace Dr. Castano as Chief Research and Innovations Officer of Nano Labs and continue move the company in the direction to generate revenues in 2014.
We are working to create products and materials that come with the satisfying investment benefit of making our industries stronger, our economies healthier, and our environment safer. The company plans to update our shareholders in the weeks to come as to the direction the company will take in 2014.
Respectfully on behalf of the Board,
Mr. Bernardo Camacho Chavarria President, Nano Labs
About Nano Labs Nano Labs Corp. (CTLE) is a nanotechnology company whose research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us.
Forward-looking statements This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.
reference: http://www.barchart.com/headlines/story/3776188/nano-labs-shareholder-update
When are the warrants due to be exercised? I might just wait until after they are to get back in, please advise and thank you for your imput
A sincere WARNING on PSID
Folks...please note that cash strapped companies with less than 250K at their disposal have a 99% failure rate, let alone one with the Herculean amounts of debt. I have lost money on this stock overall and even with a contract in place they are years away of getting out of debt. Don’t throw away your money on this one. A year from now you will have an empty account and a list full of promises. Check YOUTUBE and look up the key word HOTSTOCK, they make it very clear. I am now invested in a biomed company with 17 million in cash and getting healthy gains. This stock is FOOLS GOLD!
GODSPEED
C
FORM 8-K
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
Nano Labs Corp., a Colorado corporation (the "Company") reports in this Current Report on Form 8-K a change in certifying accountants. Effective January 20, 2014, the Company dismissed Patrick Rodgers, CPA, P.A. ("Rodgers") as its's independent registered public accounting firm. The Company has engaged Terry L. Johnson, CPA ("Johnson") as its principal independent registered public accounting firm effective January 20, 2014. The decision to change its principal independent registered public accounting firm has been approved by the Company’s board of directors.
The reports of Rodgers on the Company's financial statements for fiscal year ended June 30, 2013 (which included the balance sheet as of June 30, 2013 and the statement of operations, cash flows and stockholders' equity as of June 30, 2013, for the past fiscal year, did not contain an adverse opinion or a disclaimer of opinion, nor qualified or modified as to uncertainty, audit scope or accounting principles, other than to state that there is substantial doubt as to the ability of the Company to continue as a going concern. During the Company’s fiscal year ended June 30, 2013 and during the subsequent period through to the date of Rodgers' resignation, there were no disagreements between the Company and Rodgers, whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of Rodgers, would have caused Rodger to make reference thereto in its report on the Company’s audited financial statements.
The Company has provided Rodgers with a copy of this Current Report on Form 8-K and has requested that Rodgers furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Rodgers agrees with the statements made in this Current Report on Form 8-K with respect to Rodgers and, if not, stating the aspects with which they do not agree. The Company has received the requested letter from Rodgers wherein he has confirmed his agreement to the Company’s disclosures in this Current Report with respect to Rodgers. A copy of Rodgers' letter has been filed as an exhibit to this Current Report.
In connection with the Company’s appointment of Johnson as the Company’s principal registered accounting firm at this time, the Company has not consulted Johnson on any matter relating to the application of accounting principles to a specific transaction, either completed or contemplated, or the type of audit opinion that might be rendered on the Company’s financial statements during the two most recent fiscal years (June 30, 2013 and 2012) and subsequent interim period through the date of engagement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NANO LABS CORP.
DATE: January 21, 2014 By: /s/ Bernardo Camacho Chararria
Name: Bernardo Camacho Chararria
Title: President/Chief Executive Officer
reference: archive.fast-edgar.com//20140122/A5ZCK22CZ22FH2P2222N2WZ2Q9OAZZ276262/
PositiveID Publishes Report on Its BioThreat Detection and Diagnostics Solutions
Jan 23, 2014 08:30:00 (ET)
PositiveID Publishes Report on Its BioThreat Detection and Diagnostics Solutions
DELRAY BEACH, Fla., Jan. 23, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it has published a report on the current market opportunities for its homeland security and medical diagnostics technologies.
"The bio-detection market has seen a surge in funding over the past decade," stated William J. Caragol, Chairman and CEO of PositiveID. "This increase can be directly attributed to events that have occurred since the beginning of the 21st century such as the Anthrax scare in 2001, the SARS outbreak in 2003, the ricin letters in 2004, the H1N1 health crisis in 2009, and most recently the concern over Syrian and North Korean biological and chemical weapons programs."
Mr. Caragol continued, "The urgent requirement for public healthcare and homeland security agencies to institute an early detection system for bio-terrorist attacks and infectious disease outbreaks is at hand. PositiveID's technologies reduce the time to both detect the presence of a threat and diagnose affected persons, enabling the deployment of countermeasures and vaccines in a time frame where casualties and fatalities can be drastically reduced. Our products are capable of revolutionizing not only our nation's response to bioterrorism but also improving medical testing at the point of need."
A copy of the report is available on PositiveID's website at http://www.positiveidcorp.com/files/PositiveID_Market_Opportunities_2014-01-24.pdf.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including, without limitation, the likelihood that the Company's products are capable of revolutionizing not only our nation's response to bioterrorism but also improving medical testing at the point of need; and all statements in this press release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company's ability to target the bio-threat detection and rapid medical testing sectors; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 28, 2012, as amended on May 4, 2012, and 10-Qs filed on November 16, 2012, August 20, 2012, as amended on September 12, 2012, and May 14, 2012, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT: PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
(MORE TO FOLLOW) Dow Jones Newswires
January 23, 2014 08:30 ET (13:30 GMT)
Form 4
Statement of Changes of Beneficial Ownership
Filed Jan 16, 2014
http://investors.positiveidcorp.com/secfiling.cfm?filingID=1437749-14-701&CIK=1347022
Mike Campbell is endorsed by MIKE HUCKABEE!
reference:http://www.ourcampaigns.com/CandidateDetail.html?CandidateID=43887
Nano Labs Signs Letter of Intent With Polec to Advance Proprietary Technology to Address the Construction Industry's Need for Low-Cost, Self-Sustainable, and Scalable Construction Material
Jan 13, 2014 10:11:00 (ET)
Nano Labs Signs Letter of Intent With Polec to Advance Proprietary Technology to Address the Construction Industry's Need for Low-Cost, Self-Sustainable, and Scalable Construction Material
DETROIT, MI--(Marketwired - Jan 13, 2014) - Nano Labs Corp. (OTCQB: CTLE) ("Nano Labs" or "The Company") is pleased to announce it has signed a Letter of Intent (LOI) with Polec SA de CV ("Polec") with respect to an agreement between the parties to acquire and develop a technology that creates new ecofriendly, green building material solutions for government infrastructure, industrial, and residential construction projects.
The LOI sets forth the principal terms of the partnership between the companies in connection with the continued development of Polec's proprietary polymer-based, soil stabilizer and other construction material product(s).
The companies are furthering technical due diligence workshops and business plans to further continue nano research and development of the new product, manufacturing, operations, and business development efforts to get the new product to market in the first quarter of 2014.
The current technology, a 100% organic, water-based emulsified polymer, when added to almost any type of soil such as Earth, Sand or Clay it creates a stone-like brick, block and/or panel. The organic polymers function as a cementing and bonding agent which increases and optimizes the molecular attraction of the soil, controlling the expansion and linear contraction, thus increasing the amount of carrier load and resistance suitable for construction applications, essentially creating a stone like building material.
The polymer is dissolved in water and added to the naturally occurring soil available on the construction site. The combination creates a thick, malleable mixture that can be molded to form and specification. The stone bricks air dry and are immediately ready for commercial use. Finished stone bricks are ideal for floors to walls, in both commercial and residential building projects, and can also be poured as a single, continuous set ideal for parking lots and roads. The product is environmentally friendly, non-toxic, water-resistant, and presents the advantages of requiring no special equipment, electricity, or ovens, and eliminates significant costs associated with materials transport and handling. This new technology could be used for road construction replacing asphalt or cement around the world.
"We are very pleased to be working with Polec's innovative team of engineers. Imagine turning a dirt road into a cement like surface without any additional aggregates. There is tremendous potential for this product to be a very cost-effective alternative and replacement in the construction industry. We are moving forward quickly to finalize the joint venture agreement," comments Mr. Bernardo Camacho Chavarria, President of Nano Labs.
About Nano Labs
Nano Labs Corp. (the "Company") (OTCQB: CTLE) is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use, and integration of proprietary nano compounds, our goal is to evolve common products, into new, revolutionary products, in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.Nanolabs.us.
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.
Contact:
Nano Labs Corp.
Bernardo Camacho Chavarria
President
1 (888) 806-2315
www.NanoLabs.us
(MORE TO FOLLOW) Dow Jones Newswires
January 13, 2014 10:11 ET (15:11 GMT)
Interesting! They are up to something....GOOD?!?
http://www.positiveidcorp.com/investors_secfilings.html
I think you might be right on this! Below is what was said on CTLE's latest 10-Q report:
LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2013, our current assets were $6,798 and our current liabilities were $21,990,042, which resulted in a working capital deficit of $21,983,244. As of September 30, 2013, current assets were comprised of $6,798 in cash. As of September 30, 2013, current liabilities were comprised of: (i) $2,568 in accounts payable; (ii) $916,000 in convertible notes payable; and (iii) $21,071,474 in derivative liability. See " -- Material Commitments".
As of September 30, 2013, our total assets were $6,798 comprised of current assets. The decrease in total assets during the three month period ended September 30, 2013 from fiscal year ended June 30, 2013 was primarily due to a decrease in cash.
As of September 30, 2013, our total liabilities were $21,990,042 comprised entirely of current liabilities. The increase in liabilities during the three month period ended September 30, 2013 from fiscal year ended June 30, 2013 was primarily due to the increase in the derivative liability of $11,623,033.
Stockholders’ deficit increased from ($10,194,010) as of June 30, 2013 to ($21,983,244) as of September 30, 2013.
Cash Flows from Operating Activities
We have not generated positive cash flows from operating activities. For the three month period ended September 30, 2013, net cash flows used in operating activities was ($171,398) compared to ($-0-) for the three month period ended September 30, 2012. Net cash flows used in operating activities consisted primarily of a net loss of $11,789,234 (2012: ($10,092), which was adjusted by $11,623,033 (2012: $-0-) of derivative interest calculated from the outstanding convertible notes. Net cash flows used in operating activities was further changed by ($5,197) (2012: $-0-) of accounts payable and accrued expenses and $-0- (2012: $10,092) in related party payables.
Cash Flows from Investing Activities
For the three month period ended September 30, 2013 and September 30, 2012, net cash flows used in investing activities was $0.
Cash Flows from Financing Activities
We have financed our operations primarily from debt or the issuance of equity instruments. For the three month period ended September 30, 2013, net cash flows provided from financing activities was $150,000 compared to $0 for the three month period ended September 30, 2012. Cash flows from financing activities for the three month period ended September 30, 2013 consisted of $150,000 in proceeds from convertible notes payable.
PLAN OF OPERATION AND FUNDING
We expect that future working capital requirements will to be funded through a combination of our existing funds, debt and equity, and potential generation of revenues. Our working capital requirements are expected to increase in line with the growth of our business.
Our principal demands for liquidity are to increase research and development, capacity for developing products, inventory purchase, potential sales distribution, and general corporate purposes. We intend to meet our liquidity requirements, including capital expenditures related to the purchase of equipment and/or inventory, and the expansion of our business, through cash flow provided by funds raised through proceeds from the issuance of debt or equity.
Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next six months. We have no lines of credit or other bank financing arrangements. We may finance expenses with further issuances of securities and debt issuances. Any additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all.
8
--------------------------------------------------------------------------------
MATERIAL COMMITMENTS
Convertible Note Payable
On December 30, 2012, the Company entered into a convertible promissory note with Globe Financial Corp. for $201,000 bearing no interest and convertible at a 50% discount to market. The note is payable on demand. Since the conversion rate is discounted to market, the Company calculated a derivative liability of $2,455,751 at June 30, 2013 using the Black Scholes Model, plus for the three months ended September 30, 2013 an additional $2,870,684.
On December 31, 2012, the Company entered into a convertible promissory note with Globe Financial Corp. for $90,000 bearing no interest and convertible at a 50% discount to market. The note is payable on demand. Since the conversion rate is discounted to market, the Company calculated a derivative liability of $1,175,578 at June 30, 2013 using the Black Scholes Model and recorded an additional $1,374,256 for the three months ended September 30, 2013.
On January 5, 2013, the Company entered into a convertible promissory note with Asus Global Holdings Inc. for $475,000 bearing no interest and convertible at a 50% discount to market. The note is payable on demand. Since the conversion rate is discounted to market, the Company calculated a derivative liability of $5,817,112 at June 30, 2013 using the Black Scholes Model and recorded an additional $6,800,150 for the three months ended September 30, 2013.
In the three months ended September 30, 2013 the Company entered into a new convertible note agreement with Asus Global Holdings for $150,000 with the same terms as previously noted. The Company recorded a derivative liability of $577,943 using the Black Scholes Model.
At September 30, 2013, the balance due against these four convertible notes was $916,000. In connection with the issuance of these convertible notes the Company recorded a derivative liability of $21,071,474 as of September 30, 2013.
PURCHASE OF SIGNIFICANT EQUIPMENT
We do not intend to purchase any significant equipment during the next twelve months.
OFF-BALANCE SHEET ARRANGEMENTS
As of the date of this Quarterly Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
GOING CONCERN
The independent auditors' report accompanying our June 30, 2013 and June 30, 2012 financial statements contains an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business. We have suffered recurring losses from operations, have a working capital deficit and are currently in default of the payment terms of certain note agreements. These factors raise substantial doubt about our ability to continue as a going concern.
reference: http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001477932%2D13%2D005488%2Etxt&FilePath=%5C2013%5C11%5C14%5C&CoName=NANO+LABS+CORP%2E&FormType=10%2DQ&RcvdDate=11%2F14%2F2013&pdf=
REHABILITARÁN EL CENTRO DE CONVENCIONES DE MADERO...
This is a REAL project, acording to an article from TELEVISA DEL GOLFO posted on April 2nd! (article is in spanish)
http://www.televisaregional.com/del-golfo/noticias/Rehabilitaran-el-Centro-de-Convenciones-de-Madero-201145351.html
***This the way I am playing this one***
Trust me folks when I tell you that I understand the optimism and pessimism on this board. There are real concerns here. I have done my DD on this company and have noticed the laundry list of LOI’s since its inception, with NO revenue to be found. This is a BIG red flag! The amount of employees has also made me raise a brow. These are all signs of a company that is going down the tubes and taking our money with them!
But…there is room for optimism. I have watched one the CEO’s speeches on YouTube the other day (yes, I am a fluent Spanish speaker) and I came away with his speech with much optimism! I spent a good part of my childhood in Sonora, Mexico. The way business is carried out there is different than here. In order to do big business with certain companies in Mexico you MUST have the right connections and be willing to give a little or sometimes a lot! A company like Fintegra is holding they keys to CTLE’s success and wants a BIG cut of the action. This is the way it is done over there…PERIOD!
Here is my take…I find it interesting that “Anti-Corrosion Paint” that is currently being applied on the “Convention Center Ciudad Madero in Tampico” is still being negotiated!?! (The total value of the contract is currently be negotiated and will be disclosed shortly) -http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94713035 WHAT!?! Why would you be applying your product with no firm value of the contract? Since the announcement we still do not know the value of said “job”.
Now with that…I say this…In my opinion this company (if it is real) is trying to find traction and doing everything in its power to make money! This makes perfect sense for all officers of the company as well as the common share holder. All parties involved stand to make a fortune if they can just get some money coming in (and it sounds like this will happen in the very near future!) I will hold onto my shares until the Q1 2014 report. At that point I will know to either STAY or BOUNCE. Until then I will continue to purchase shares and enjoy everyone’s comments from this board. Merry Christmas!
Semper Fi,
Cayaboxing
Nano Labs' President, Mr. Bernardo Camacho stated...
"Pemex maintains billions of dollars of assets in the field and this is obviously a starting point for us in this niche market within the petrochemical industry. We are presently in discussions with Pemex's maintenance divisions for our other coating applications as it applies to the various challenges at refineries across Mexico. We are very bullish on the future outlook of our nano coatings in the global marketplace, and this contract lends great credibility to our nano coating product lines. Our plan is to continue to push hard in the North America and International markets. We believe this could generate strong revenue streams for the Company, drive us forward into profitability, and have a positive impact for our shareholders."
Reference: finance.yahoo.com/news/nano-labs-secures-first-contract-152235005.html
Nano Labs Anti-Corrosion Paint Utilized in Rehabilitation of Convention Center
Dec 06, 2013 07:10:00 (ET)
Nano Labs Anti-Corrosion Paint Utilized in Rehabilitation of Convention Center
The Company is Pleased to Announce That Its Nano Coating, Corrosion Protection Paint, Is Currently Being Installed at the Convention Center Ciudad Madero as Part of Major Rehabilitation Project and Comprehensive Maintenance Program
DETROIT, MI--(Marketwired - Dec 6, 2013) - Nano Labs Corp. ("Nano Labs" or the "Company") (OTCQB: CTLE) is pleased to announce the application of its proprietary nano coating, corrosion protecting paint, currently being installed at the Convention Center Ciudad Madero in Tampico, Mexico.
The Convention Center Ciudad Madero, originally constructed in 1982, is primarily used for cultural and sporting events, as well as the meeting place for Pemex's Section One Union. The building, which has a capacity for up 10,000 people, was covered by a large galvanized steel dome, which has gradually deteriorated and is currently undergoing a comprehensive maintenance program. Please visit the website at http://wikimapia.org/237293/es/Centro-de-Convenciones-de-Ciudad-Madero
Nano Labs proprietary, anti-corrosion paint is currently being applied to the structure to prevent further corrosion and protect the buildings infrastructure. Atencio & Atencio, together with DIASA a certified maintenance supplier for Pemex, took delivery and began installation on November 25th, 2013, with completion of the project expected in Q2 2014. This maintenance program required of an extensive test of the different solutions that were proposed to address the specific needs to protect the building infrastructure. After the results of evaluations, DIASA confirmed that using the Nano Labs Aluminized Primer the steel parts, girders and beams would be not only better protected but also would be having a beautiful natural aluminum finish, saving costs and time on execution, since the Aluminized Primer can be applied just after cleaning the surface from dust and grease. The total value of the contract is currently be negotiated and will be disclosed shortly.
"Corrosion is a prevalent problem in many types of industry today -- from buildings and infrastructure, through to the production and manufacturing sectors," states Mr. Bernardo Camacho, President of Nano Labs. "With our partners at A&A, we are working to strategically develop an optimal corrosion engineering and management best-practice that can not only save money in long-term maintenance programs, but also prevent damage to property and ensure public safety. We believe corrosion is a natural but controllable problem."
The Company may be releasing further physical and chemical properties of the anti-corrosion nano coating in the future, but for immediate additional information, please contact Mr. Bernardo Camacho, President of Nano Labs.
About Nano Labs Corp.
Nano Labs Corp. (OTCQB Ticker Symbol "CTLE") is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use, and integration of proprietary nano compounds, our goal is to evolve common products, into new, revolutionary products, in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.Nanolabs.us
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.
For additional information contact
Mr. Bernardo Camacho Chavarria
President
Nano Labs
1 (888) 806-2315
(MORE TO FOLLOW) Dow Jones Newswires
December 06, 2013 07:10 ET (12:10 GMT)
***Revenue this month***
This is getting ready to take off IMO...we are on the ground floor and sky is the limit! This company only needs one of its endeavors to take off for us to get rich folks!!!
THIS RIGHT HERE IMO IS REAL BIG NEWS! DRIVING THIS CO. TO AT LEAST .20 IN THE NEXT 2 WEEKS
The purchase order was issued to Atencio and Atencio and Nano Labs by Urban del Golfo S.A. de CV a supplier of products to Pemex.
Atencio and Atencio is a certified maintenance partner of Pemex since 1991 with over 30 employees who will be carrying out the installation of the intumescent fire resistant coatings at Pemex's Francisco I. Madero Refinery.
The contract, valued at approx. $630,000 USD is scheduled to be delivered on or by December 31, 2013.
"We are very pleased with today's announcement. The team has worked very hard propelling business development and today we turned the corner on driving revenue into the Company," Nano Labs' President, Mr. Bernardo Camacho stated.
"Pemex maintains billions of dollars of assets in the field and this is obviously a starting point for us in this niche market within the petrochemical industry. We are presently in discussions with Pemex's maintenance divisions for our other coating applications as it applies to the various challenges at refineries across Mexico.
REFERENCE: http://finance.yahoo.com/news/nano-labs-secures-first-contract-152235005.html
One down…one to go!
I'm here for these reasons:
PSID attracts a partner who is a "big fish;" (Boeing)
PSID is bought out by a "big fish;" (could be Boeing in the future)
PSID becomes a "big fish" with an appropriate share price. (With serious revenue)
It is only a matter of time until 2 out of the 3 happens! One down…one to go!Look at the big picture people!
Voted this morning....NO! 180+K on www.proxyvote.com via ETRADE
DHS releases RFP for BioWatch Gen 3 to PositiveID
PositiveID Corporation, a developer of biological agent detection equipment, recently announced that it is has received a draft request proposal from the U.S. Department of Homeland Security for the first stage of the BioWatch Generation 3 project.
BioWatch Generation 3 is slated to become the fully automated third iteration of the U.S. biodetection system specifically designed to protection the nation from biological threats. PositiveID said that it expects the final request for proposal to be released in the government’s third of fiscal year 2013.
The eventual contract for stage one is expected to have a performance period of 1.5 years. The final BioWatch Gen 3 rollout is estimated to be valued at $3.1 billion over the next five years.
“We believe that PositiveID is well positioned for BioWatch Generation 3, as our M-BAND detection technology was the only system of its kind successfully demonstrated in the field as part of the DHS Science & Technology Directorate BAND (BioAgent Autonomous Networked Detector) Program,” William Caragol, PositiveID’s chairman and CEO, said.
M-BAND refers to the Microfluidics-based BioAgent Autonomous Networked Detector developed by PositiveID under a DHS S&T contract. It is a bioaerosol monitor with fully automated and integrated sample collection, processing and detection modules. M-BAND continuously samples the air for a select number of dangerous bacteria, viruses and toxins.
“In October 2012, we issued a corporate update to our stockholders about the BioWatch program, stating that we were in discussions with strategic partners to manufacture and sell M-BAND, and reiterating our belief that the BioWatch program would soon begin to roll out,” Caragol said. “The release of the draft RFP for Stage 1 of BioWatch Generation 3 validates this belief and re-confirms the U.S. Government’s focus on protecting the nation from biological threats.”
reference: Published on February 11, 2013 by Ted Purlain
Former Sergeant U.S.M.C.
1990 – 1998
Former Professional Boxer
Now I am working for DHS and am building on my 100K share investment!!!
Semper Fi...and GODSPEED
Form SC 13D/A
Amended General Statement of Beneficial Ownership
Filed Nov 30, 2012
Scott R. Silverman
Mr. Silverman beneficially owns 15,563,379 Shares, representing 6.75% of the outstanding Shares.
Mr. Silverman has sole voting power and dispositive power over 12,174,371 Shares held directly by Mr. Silverman, which includes 250,000 shares underlying currently exercisable options.
Mr. Silverman shares voting power and dispositive power over 3,389,008 Shares. These Shares consist of (i) 54,000 Shares underlying a currently exercisable warrant that Mr. Silverman, as manager of Blue Moon Energy Partners LLC (“Blue Moon”), may be deemed to share beneficial ownership with Blue Moon, and (ii) 3,335,008 Shares that Mr. Silverman, as the control person of R & R Consulting Partners, LLC (“R&R”), may be deemed to share beneficial ownership with R&R.
R&R
R&R beneficially owns 3,335,008 Shares, representing 1.45% of the outstanding Shares. Mr. Silverman, as the control person of R&R, may be deemed to share voting power and dispositive power with R&R over the 3,335,008 Shares.
(c) As of the date of this filing, Mr. Silverman has sold a total of 3,361,392 shares. No other transactions involving the securities of the Issuer were effected by R&R or Mr. Silverman in the last 60 days . The following open market sales were made by Mr. Silverman:
Date Total Number of shares Sold Weighted Average Price per Share (1) Price Range for the Day
10/16/2012 98,000 0.0236 0.0232 - 0.0240
10/17/2012 143,500 0.0209 0.0200 - 0.0220
10/18/2012 114,000 0.0198 0.0196 - 0.0210
Date Total Number of shares Sold Weighted Average Price per Share 1 Price Range for the Day
10/19/2012 50,000 0.0192*
10/22/2012 200,000 0.0196 0.0190 - 0.0210
10/23/2012 103,000 0.0200*
10/24/2012 184,893 0.0202 0.0195 - 0.0215
10/25/2012 102,000 0.0195 0.0190 - 0.0200
10/26/2012 156,900 0.0201 0.0190 - 0.0209
10/31/2012 15 0.0199*
11/01/2012 143,013 0.0193 0.0190 - 0.0199
11/02/2012 100,500 0.0182 0.0180 - 0.0185
11/05/2012 84,471 0.0178 0.0175 - 0.0180
11/06/2012 745,000 0.0231 0.0200 - 0.0250
11/07/2012 300,300 0.0251 0.0230 - 0.0270
11/08/2012 38,300 0.0220*
11/09/2012 130,000 0.0209 0.0206 - 0.0210
11/12/2012 195,500 0.021 0.021 - 0.021
11/14/2012 46,000 0.0181* 0.0181 - 0.0181
11/19/2012 96,500 0.0180* 0.0180 - 0.0180
11/20/2012 75,500 0.0171 0.0171 - 0.0180
11/21/2012 52,500 0.0170* 0.0170 - 0.0170
11/26/2012 110,000 0.0180** 0.0180 - 0.0180
11/27/2012 51,500 0.0170* 0.0170 - 0.0170
11/29/2012 40,000 0.0170* 0.0170 - 0.0170
Explanation:
(1) The price reported is the weighted average price. The shares were sold in multiple transactions. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the Price Range for the Day column.
* Denotes the actual price per share. Shares were sold in a single transaction, and hence there is no price range for the day.
**Denotes the actual price per share. Shares were sold in multiple transactions, but the price per share did not fluctuate. Hence all shares were sold in multiple transactions on the same day, but the price per share remained the same.
(d) No other person is known to have a right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares beneficially owned by Mr. Silverman or R&R.
reference: http://www.positiveidcorp.com/investors_secfilings.html
Very Interesting...look at the date!
PositiveID (PSID) Partners With Boeing (BA) & United Technologies (UTX) Subsidiary on $3 billion Biowatch Opportunity
Despite the way things are 'supposed to be', the fact is, America's biggest and best-funded companies don't always come up with America's biggest and best ideas - small, hungry, and nimble companies still make most of this country's technological leaps, and just happen to bring the bigger players along for the ride. Case in point? Bio-threat detection outfit PositiveID Corporation (OTC:PSID) has developed an amazing device that scans the air for bio-warfare agents like anthrax; the device can operate on its own for 30 days. Sure enough, The Boeing Company (NYSE:BA) and United Technologies Corporation (NYSE:UTX) subsidiary Hamilton Sundstrand are more than happy to be part of the 'presenting' team now that PositiveID will have an audience to unveil the technology to.
In simpler terms, Boeing, United Technologies' Hamilton Sundstrand, and PositiveID Corporation are going to present the newly-developed 'M-BAND' (Microfluidics-based Bioagent Autonomous Networked Detector) technology at the upcoming Annual American Society for Microbiology Biodefense and Emerging Diseases Research Meeting.
The connection between PositiveID, Boeing, and Hamilton Sundstrand isn't perfectly clear yet. PSID developed the technology using its deep expertise of biological sensors; the company is also working on some incredible blood glucose-monitors for diabetes patients. Presumably, Hamilton Sundstrand and Boeing are interested in the technology too, if not as an outright suitor, then at least as a partner (manufacturing, marketing, etc.). Either way, their involvement with PositiveID Corporation on this particular piece of equipment is a subtle but exciting - even if unintentional - acknowledgement that there's something to the technology.
The joint-presentation will happen between February 26th and 29th at, as was noted above, the 10th annual ASM Biodefense and Emerging Diseases Research Meeting. No, it doesn't sound like a barnburner of a convention, but it's a huge deal within the biodefense community just because it will showcase M-BAND in front of key decision-makers within the nation's biodefense social circle. As such, the event alone could spark some buying (or buyout?) interest in the stock. That being said, there's an even bigger deal down the road for investors.
While the Boeing/PositiveID/Hamilton Sundstrand presentation of the M-BAND technology at the conference will surely cause a stir, the device is ultimately going to be presented to the Department of Homeland Security as a solution to its need for bio-warfare defense solutions.
As part of its 'BioWatch Gen-3 Autonomous Biodetection System' initiative to further improve the country's bio-agent defense capacity, the DHS has set aside $3 billion for the purchase of a technology that meets this criteria: "[the] detection system will be a fully autonomous network of biodetectors that will continuously monitor the air for biothreat agents of Public Health concern in designated jurisdictions in the United States." In other words, these things need to be self-contained, easy to use, easily and readily manufactured, and effective. M-BAND satisfies all those requirements.
Now, as nice as it would be to think the Department of Homeland Security (or any government agency for that matter) is going to choose suppliers in an equitable way that puts performance first and notoriety second, most investors aren't that naive. That's where involvement from the Boeing Company and the United Technologies Corporation subsidiary comes back into play...those two players can certainly get the attention of any procurement people. In that light, their involvement with PositiveID (whatever it really is) is a very good thing for PSID shareholders. On that note...
One way or another, that $3 billion is going to be spent by the DHS. Boeing and Hamilton Sundstrand - two companies that know as well as anyone how government contracts are won - have hitched their wagon to PositiveID's technology rather than developing their own. That's not likely to be a mere coincidence.
reference: http://www.smallcapnetwork.com/PositiveID-PSID-Partners-With-Boeing-BA-United-Technologies-UTX-Subsidiary-on-3-billion-Biowatch-Opportunity/s/via/6540/article/view/p/mid/1/id/100/
By Matthew Briar
Feb 22, 2012 9:09:06 AM PST
More findings...I found this interesting:
In May 2011, we acquired MicroFluidic Systems ("MicroFluidic"), pursuant to which MicroFluidic became our wholly-owned subsidiary. MicroFluidic specializes in the production of automated instruments for a wide range of applications in the detection and processing of biological samples, ranging from rapid medical testing to airborne pathogen detection for homeland security. MicroFluidic's substantial portfolio of intellectual property related to sample preparation and rapid medical testing applications are complementary to our portfolio of diabetes management products. Since its inception, MicroFluidic has received over $45 million in U.S. Government contracts, primarily from DHS. Since our acquisition of MicroFluidic, we have submitted, and are in the process of submitting, bids on various potential U.S. Government contracts, and are planning to pursue the DHS's third generation BioWatch program (for the development of networked, autonomous, bioagent detection systems). DHS has estimated the first contract period to be five years and has projected the draft request for proposal for this program will be issued during the fourth quarter of 2012.
Reference: http://www.barchart.com/headlines/story.php?id=7405852
10-Q: POSITIVEID CORP
Edgar Online via CMTX - Fri Nov 16, 4:22PM CST
(please read 10-Q in it’s entirety)
*****Case in point*******
ALCON,
As you could probably could figure out by my member profile...I was a fighter...a professional boxer that had a good although brief career and that is all I will say about that. Since my retirement I have been working for the Department of Homeland security for over six years now. I have recently purchased over 100K shares in PSID for one simple fact...I have worked with the great folks at SAIC. SAIC is the real deal!
I am not a trader...I am an investor. I look this investment like this...PSID has a great chance now of landing all or part of the initial contract, if they land it I have all the confidence in the world that working with SAIC...SAIC will do a tremendous job of moving this project along. Case in point...PSID has the technology and SAIC knows how all this gets supported and moved along. I give PSID a better than fifty percent chance to end up over the three dollar mark in as little as a year pending a contract. Just my opinion...not advice
GOD SPEED
Semper Fi,
Cayaboxing
http://www.positiveidcorp.com/investors_events.html
Please read .pdf
Interesting?!?
Accession Number 1104659-12-72724 · SEC File 333-179146
insert-text-here
RE: Today’s Article
We have all had investments that have failed, although ONCOSEC has used some of the same tactics to promote this company it does not make it a fraud. This company has put itself “out there” for the whole world to see the REAL progress of the science behind it. I doubt very much that several Doctors throughout the country as well as the venture capitalists would have their careers linked to a company that has a chance of ruining all that they have worked for. Bottom line is that the science is REAL and the world is watching!
GODSPEED & SEMPER FI
ONCOSEC is positioning itself rather well for a near future buyout (within 3 years IMO). The PR and more importantly their strong clinical data along with positioning of its Intellectual Property and patents is something that is absolutely enticing for the big boys to bust out their check book! I am LONG on (ONCS)
Godspeed and Semper Fi
The Company believes that this acreage is sufficient for the Company's initial phase of operations, which consists of between 20 and 40 wells, the first four of which are ready for production to recommence. If the initial phase of the Company's plan of operation is fully implemented, the Company will continue to test and complete additional wells over the next two years.
reference: http://eagleoilholdingco.com/wp-content/uploads/2012/05/Complete-2012-Filing.pdf
I think we might be kicking it into high gear here very soon!
GODSPEED-
You are only as old as the woman that you feel :)
Go EGOH!!!
Reason for optimism...
Here is my big reason; our CEO is not acting alone on this news…after all Mr. Barwiki is involved as well as DME Capital LLC. These people are not going to go down for anyone! Let alone a 70 year old man. I just think...maybe just this once...that THIS OIL PUMPING THING MIGHT JUST HAPPEN AFTER ALL. The saga continues...
Godspeed
RE: “believes,” “should,” “intends,” “will,” or “plans”
ALCON,
My letter of “intent” to all is not to buy anymore shares until I see a quarterly report with some revenue. I am a realist and an optimist, that being said our fearless CEO has NEVER made this company even somewhat profitable. I have a good amount of shares and will wait on “real” news about this company. Terms such as “believes,” “should,” “intends,” “will,” or “plans” don’t mean anything to me. Only production! I hope for once in his life the CEO does the right thing.
Semper Fi
Has anyone talked to our fearless CEO as of late?
BTW...BKMUC, I agree :)
Let’s keep one thing in mind...if EGOH starts pumping we are rich! It’s as simple as that
EGOH...it is time to fly!
Semper Fi & Godspeed
OncoSec Medical Inc. Enters Into Exclusive Manufacturing Agreement with VGXI Inc. for Production of Interleukin-12 Plasmid DNA
Read more here: http://www.sacbee.com/2012/06/05/4538761/oncosec-medical-inc-enters-into.html#storylink=cpy
Current and Planned Operations
Our leased oil field contains 173 existing wells each of which requires reconditioning prior to being able to return to oil production. The initial phase of the Company's plan of operation involves re-conditioning and testing wells on the leased acreage to prove reserves, completing promising test wells, extracting the oil, gas and other hydrocarbons that the Company finds, and delivering them to market. The Company believes that this acreage is sufficient for the Company's initial phase of operations, which consists of between 10 and 20 wells. If the initial phase of the Company's plan of operation is fully implemented, the Company will continue to test and complete additional wells over the next two years. Currently, the Company is ready to commence production at its first four reconditioned wells, pending clearance from the Texas Railroad Commission that monitors the oil production facilities in Texas.
The Company is negotiating new agreements with other companies to act as the operators of the Company's wells. Although the Company presently does not intend to seek status as a licensed operator, if in the future the Company believes that seeking licensed operator status is appropriate and the Company has adequate staff available to it, the Company may decide to operate other wells.
reference: http://eagleoilholdingco.com/wp-content/uploads/2012/05/Complete-2012-Filing.pdf